CAN10 (LALA)
CAN10 (LALA) is is a humanized monoclonal antibody inhibitor targeting interleukin 1RAP (IL1RAP). CAN10 (LALA) blocks IL-1, IL-33, and IL-36 signalling by targeting IL1RAP, preventing downstream proinflammatory and profibrotic responses. The Fc region of CAN10 (LALA) incorporates the L234A and L235A mutations, which are designed to reduce the binding of the antibody to FcγRs and C1q, thereby attenuating or eliminating the antibody’s ADCC (antibody-dependent cell-mediated cytotoxicity) and CDC (complement-dependent cytotoxicity) effector functions. CAN10 (LALA) reduces dermal and pulmonary fibrosis. CAN10 (LALA) can be used for the research of immune system diseases, such as systemic sclerosis.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
IL1R1 |
IL-1 |
IL-13 |
IL-36 |
In Vitro
CAN10 (LALA) effectively impairs the proinflammatory and profibrotic effects of IL1RAP-related cytokines (IL-1, IL-33, and IL-36) in human umbilical cord endothelial cells and human dermal fibroblasts, which are critical to systemic sclerosis pathophysiology[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
SMILES
[CAN10 (LALA)]
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)